. 2023 Nov 1;8(45):42248–42263. doi: 10.1021/acsomega.3c04175

Table 1. Anti-SARS-CoV-2 Activity of Vitamin K Derivatives in VeroE6/TMPRSS2 Cells^a.

graphic file with name ao3c04175_0010.jpg

RDV: remdesivir; EC₅₀: 50% effective concentration based on the inhibition of virus-induced cell destruction; CC₅₀: 50% cytotoxic concentration based on the reduction of mock-infected cell viability; ND: not determined.

Table 1. Anti-SARS-CoV-2 Activity of Vitamin K Derivatives in VeroE6/TMPRSS2 Cellsa.

Table 1. Anti-SARS-CoV-2 Activity of Vitamin K Derivatives in VeroE6/TMPRSS2 Cells^a.